Neuroendocrine Tumor Treatment in the Era of Transplant Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Transplant Oncology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 339
Special Issue Editors
Interests: liver transplantation; split liver transplantation; living donor liver transplantation; machine preservation technolo-gies; expansion of liver allograft utilization; extended criteria donor; DCD; transplant oncology; hepatocellular carcinoma; cholangiocarcinoma; NET; transplant immunosuppression; tolerance; rejection
Interests: DCD liver transplantation; machine preservation technologies; expansion of liver allograft utilization; transplant oncology; hepatocellular carcinoma; cholangiocarcinoma; NET; PDAC; international comparative analyses on liver transplant & hepatobiliary cancer surgery
Special Issue Information
Dear Colleagues,
Due to the success in the treatment of end-stage liver diseases, the indications for liver transplantation (LT) have broadened in recent decades. Transplant oncology is an expanding field in the LT domain, which encompasses liver oncological indications (primary or secondary) for transplantation. After hepatocellular carcinoma, liver metastases from unresectable neuroendocrine neoplasms (NELM) were the first accepted and established malignant indication for transplantation. This Special Issue on Cancers focuses on updates on LT as an NELM treatment, as well as surgical and non-surgical interventional procedures, and recent advances in medical treatment. It is also dedicated to discussing advances in the molecular, biological, and radiological characterizations of NELM, improvements in patient criteria in addition to surgical technique and graft selection for this specific transplant indication, and the specificities of post-transplant patient care, such as immunosuppression protocols, monitoring, and treatment of possible recurrences.
Dr. Eliano Bonaccorsi-Riani
Dr. Emmanouil Giorgakis
Dr. Laurent Coubeau
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroendocrine neoplasms
- NEN
- pancreatic NEN liver metastases
- unresectable neuroendocrine liver metastases
- transplant oncology
- NELM
- liver transplantation
- immunosuppression
- recurrence monitoring
- recurrence treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
